Azoulay Salomon
Transaction: 08/04/2026
SELL
Change
-370
Price
$65.77
Filing
08/05/2026
Type
SELL
MBX Biosciences, Inc. Common Stock
MBX • Biotechnology
$61.72
▲ +0.30 (+0.49%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$2.94B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 24.62Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:04 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$61.72
Change0.49%
Shares Out47.70M
Market Cap$2.94B
Enterprise Value$2.53B
52W Range9.63 - 72.64
Beta0.10
P/E-28.23
P/B7.19
P/FCF-27.81
EV/EBITDA-21.89
EV/FCF-23.89
Price$61.72
Change0.49%
Shares Out47.70M
Market Cap$2.94B
Enterprise Value$2.53B
52W Range9.63 - 72.64
Beta0.10
P/E-28.23
P/B7.19
P/FCF-27.81
EV/EBITDA-21.89
EV/FCF-23.89
Earnings Yield-3.54%
FCF Yield-3.60%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio24.62
Quick Ratio24.62
Target$80.50
Target Upside30.43%
Target Median$88.00
Target Range56.00 - 90.00
Volume520.06K
Avg Volume834.21K
EPS Surprise0.11
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
77/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 24.62Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
100/100
Bullish
Bullish
7
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$56.00
Mean
$76.00
Median
$79.00
High
$90.00
Insider Transactions
Recent executive and insider activity
Hoerter Steven L.
Transaction: 08/03/2026
BUY
Change
+71,000
Price
Not reported
Filing
08/04/2026
Type
BUY
Hoerter Steven L.
Transaction: 08/03/2026
BUY
Change
+331,000
Price
$64.41
Filing
08/04/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Azoulay Salomon | SELL | -370 | $65.77 | 08/04/2026 | 08/05/2026 |
| Hoerter Steven L. | BUY | +71,000 | Not reported | 08/03/2026 | 08/04/2026 |
| Hoerter Steven L. | BUY | +331,000 | $64.41 | 08/03/2026 | 08/04/2026 |
| Smither John W | BUY | +28,000 | Not reported | 08/03/2026 | 08/04/2026 |
| Smither John W | BUY | +130,000 | $64.41 | 08/03/2026 | 08/04/2026 |
| Aynechi Tiba | BUY | +12,500 | $30.91 | 06/04/2026 | 06/05/2026 |
| Ryder Steven | BUY | +12,500 | $30.91 | 06/04/2026 | 06/05/2026 |
| Hoerter Steven L. | BUY | +12,500 | $30.91 | 06/04/2026 | 06/05/2026 |
| Stelzer Laurie | BUY | +12,500 | $30.91 | 06/04/2026 | 06/05/2026 |
| Heron Patrick J | BUY | +12,500 | $30.91 | 06/04/2026 | 06/05/2026 |
| Pescovitz Ora H. | BUY | +12,500 | $30.91 | 06/04/2026 | 06/05/2026 |
| Mathers Edward T | BUY | +12,500 | $30.91 | 06/04/2026 | 06/05/2026 |
| Azoulay Salomon | SELL | -15,003 | $38.30 | 05/08/2026 | 05/11/2026 |
| Azoulay Salomon | BUY | +15,003 | $16.00 | 05/08/2026 | 05/11/2026 |
| Hawryluk P. Kent | SELL | -607 | $29.54 | 05/06/2026 | 05/08/2026 |
| Azoulay Salomon | SELL | -231 | $29.54 | 05/06/2026 | 05/08/2026 |
| Hoerter Steven L. | BUY | +11,938 | Not reported | 05/01/2026 | 05/04/2026 |
| Hoerter Steven L. | BUY | +74,249 | $29.78 | 05/01/2026 | 05/04/2026 |
| Hoerter Steven L. | BUY | 0 | $27.08 | 11/22/2025 | 04/22/2026 |
| Hoerter Steven L. | BUY | +33,751 | $24.74 | 11/06/2025 | 04/22/2026 |